Tami L. Mark, PhD, is health economist whose research focuses on behavioral health care financing, organization, and quality measurement. She has authored more than 130 scholarly peer-reviewed journal articles and numerous government reports. She was a contributing author to the healthcare systems chapter of The Surgeon General’s Report on Alcohol, Drugs, and Health.
Dr. Mark collaborates with federal and state agencies to improve their behavior health system through data analytics, evaluation, technical assistance, and policy development. She has also served on advisory committees for the National Institutes of Health (NIH), the U.S. Government Accountability Office (GAO), the Office of the Assistant Secretary for Planning and Evaluation (ASPE), the Office of National Drug Control Policy (ONDCP), the Centers for Medicare & Medicaid Services (CMS), the Substance Abuse and Mental Health Services Administration (SAMHSA), the Agency for Healthcare Research and Quality (AHRQ), and the National Quality Forum (NQF).
Before joining RTI in 2017, Dr. Mark was a vice president of the Center for Behavioral Health Services Research at Truven Health Analytics, an IBM company, previously known as Thomson Reuters and Medstat.
Learn more about Dr. Mark's work to improve quality treatment for substance use disorders.